Welcome to the

Center for Blood Cancers

We are global leaders in the diagnosis, treatment, and research of all types of blood cancers.

Our team of experts at the Center for Blood Cancers, part of NYU Langone’s Perlmutter Cancer Center, work together to provide an innovative and individualized care plan to manage blood cancers. The hematologists, radiation oncologists, pathologists, and scientists on our team collaborate so that the discoveries in the lab lead to improved treatments and better outcomes for people with blood cancers.

Our team at the Center for Blood Cancers includes hematology specialists in myeloma, leukemia, lymphoma, and blood and marrow transplants.

We treat all types of blood cancers for adults and children, including the following:

Our goal is to provide the care you need as quickly and conveniently as possible, and we accommodate most patient appointments within three business days. To help you receive care close to home, we provide treatment and services in Manhattan, Brooklyn, Queens, and on Long Island.

Once you schedule a visit, you are paired with our expert doctors on-site. You also have access to our nationally recognized hematology specialists in myeloma, leukemia, lymphoma, and blood and marrow transplants.

Diagnosis and Treatment for Blood Cancers

Our hematologist–oncologists use the latest techniques, such as molecular profiling and chromosome analysis, to make a diagnosis, determine risk factors, and recommend appropriate treatment for you. Our goal is to achieve the best possible outcome, and we offer advanced treatment options, including targeted therapy, immunotherapy, and epigenetic treatments.

Our Center for Blood Cancers specialists at the Transplantation and Cellular Therapy Center, part of the Blood and Marrow Transplant Program, provide exceptional care for adult and pediatric patients. The program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) in recognition of the highest quality of care and laboratory practices.

We specialize in stem cell transplants, both autologous (taken from the patient’s own body) and allogeneic (from a donor), as well as immune effector cell therapies, including CAR T cell therapy, that harness the body’s immune system to fight cancer. Care for young adults, adolescents, and children who receive a blood cancer diagnosis is provided through Hassenfeld Children’s Hospital at NYU Langone.

Supportive Care for Blood Cancers

Our team cares for your emotional, physical, and mental wellbeing and provides psychosocial support during every stage of treatment. We also provide integrated and supportive care through our team of nutritionists, dieticians, social workers, and patient navigators. They work with patients and their families to help them cope with the challenges of a blood cancer diagnosis.

We host a support group at Perlmutter Cancer Center at NYU Langone Hospital—Long Island for people on Long Island who have a diagnosis for blood cancer. The group meets on the first Wednesday of every month from 1:00 to 2:30PM. For more information, please call 516-663-1058.

Blood Cancer Research and Clinical Trials

The scientists and physicians on our research team work to understand the characteristics and origin of blood cancers with the goal of preventing, diagnosing, and improving outcomes for patients. Our researchers analyze blood cancers at a cellular and molecular level and play a pivotal role in discovering new therapies.

Through our Hematology and Oncology Fellowship, we provide extensive mentorship and training to young physicians and scientists with an interest in hematology early in their careers.

We integrate basic research, translational research, and clinical research so we can offer patients a broad portfolio of available therapies. We also provide advanced treatment options for those blood cancers that may be less responsive to standard therapies. Clinical trials in leukemia, lymphoma, and myeloma are available across our locations, including on Long Island.

In addition, we are developing an extensive bank for blood and bone marrow biospecimens to facilitate research on blood cancers, with the goal of developing more effective diagnosis and treatment methods.

Learn more about the Center for Blood Cancers Research.

Make an Appointment

We have doctors throughout Manhattan, Brooklyn, Queens, and Long Island. To schedule an appointment with a provider closest to you, please view our list of doctors. If you need assistance, please call 212-731-6000.

Perlmutter Cancer Center

We provide advanced treatment for a variety of cancers and blood disorders, and are leaders in cancer research.

Learn More

Our Team of Doctors

Our team of experts includes hematologists, medical oncologists, pathologists, geneticists, radiologists, and radiation oncologists.

View All Doctors

Our Leadership

  • Faith E. Davies, MD

    Director, Center for Blood Cancers | Hematology

    Dr. Faith E. Davies is director of the Center for Blood Cancers at NYU Langone’s Perlmutter Cancer Center. She leads a team of hematologist–oncologists, pathologists, and scientists across our locations with the goal of helping the center become a global leader in the investigation and treatment of blood cancers. Dr. Davies also fosters collaboration between scientists and clinicians, ensuring that our research and our clinical practice inform each other.

    Additionally, she serves as director of the Clinical Myeloma Program and is a professor in the Department of Medicine at NYU Grossman School of Medicine. She has published more than 350 research papers and is a member of the American Association for Cancer Research and the American Society of Hematology. Dr. Davies is researching new drugs and new drug combinations for the treatment of myeloma.

    View Full Profile
  • Dr. Catherine S. Diefenbach is a lymphoma translational researcher who is director of hematology translational research and director of the Clinical Lymphoma Program. Dr. Diefenbach pioneered the use of immunotherapy in Hodgkin lymphoma. She serves as principal investigator for many lymphoma clinical trials, for therapies that include targeted therapy, immunotherapy, and radiation therapy, as well as a national clinical trial for patients with relapsed Hodgkin lymphoma. Her translational work concentrates on investigating the microbiome and how it relates to lymphoma immunity, and on novel CAR T strategies for patients with relapsed B cell lymphoma.

    View Full Profile
  • Dr. Christopher Y. Park is a clinical and research pathologist whose research focuses on blood cancers such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). His laboratory works to identify genes that regulate AML or MDS stem cell self-renewal, differentiation, and therapy resistance, with the goal of developing better ways to diagnose, monitor, and treat patients. His group is actively pursuing the development of therapeutic antibodies to treat these disorders and is also investigating the use of artificial intelligence to evaluate digital pathology images to improve diagnostic sensitivity and accuracy.

    View Full Profile
  • Dr. Gareth J. Morgan, director of multiple myeloma research, focuses on disease prevention strategies and treating patients with high-risk multiple myeloma and relapsed disease. Dr. Morgan also treats pre-myeloma conditions and conducts research on the precursors of the disease, with the aim of early diagnosis and prevention of more-advanced-stage myeloma. He has pioneered many studies on the genetics and treatment of multiple myeloma.

    View Full Profile
  • Iannis Aifantis at Center for Blood Cancers
    Iannis Aifantis, PhD

    Dr. Iannis Aifantis is the Hermann M. Biggs Professor of Pathology and chair of the Department of Pathology. His laboratory focuses on the molecular mechanisms of lymphoid and myeloid leukemia initiation and progression, using genomic and genetic approaches. Other areas of research focus include the impact of DNA methylation in stem cell transformation, mapping of long non-coding RNAs in human tumors, the impact of the 3D chromosomal architecture in cancer, and the role of stress responses in cancer malignancy.

  • Dr. Marc J. Braunstein is program director of the Hematology and Medical Oncology Fellowship and course co-director of the Hematology Organ System at NYU Long Island School of Medicine. He treats patients with various types of hematologic conditions and specializes in plasma cell disorders, particularly multiple myeloma. He also performs stem cell transplants for some of these conditions. Dr. Braunstein is involved in research involving novel immunotherapy combinations for multiple myeloma and non-Hodgkin lymphoma, and is active in enrolling patient in clinical trials on Long Island.

    View Full Profile
  • Dr. Michael L. Grossbard is the section chief in Hematology at Perlmutter Cancer Center and the chief of Hematology and Medical Oncology Inpatient Services at Tisch Hospital. Dr. Grossbard treats people with blood cancers, specializing in those with lymphoma and chronic lymphocytic leukemia (CLL), and he works to enhance clinical services and clinical trials for people who have blood or bone marrow conditions. Dr. Grossbard has developed novel antibody therapies for lymphoma that have now become the standard of care, and he participates in research trials to develop new treatments for blood cancers. He has been listed in Castle Connolly’s “Top Doctors” series for the New York metro area and America’s Top Doctors for more than 20 years.

    View Full Profile
  • Mohammad Maher Abdul Hay, MD

    Hematology, Bone Marrow Transplant

    Dr. Mohammad Maher Abdul Hay, associate professor of medicine at NYU Langone, is the director of the Clinical Leukemia Program. He is also the medical unit director of the hematology–oncology and blood and marrow transplant service. Dr. Abdul Hay treats people with leukemia, myelodysplastic syndrome (MDS), and myeloproliferative disease (MPD), and is also a member of the blood and bone marrow transplant team. He provides CAR T cell therapies and autologous and allogeneic stem cell transplant services for patients. His research focuses on creating more effective targeted therapies for people with acute leukemias and myeloid malignancies by conducting early-phase clinical trials.

    View Full Profile
  • William L. Carroll, MD

    Pediatric Hematology-Oncology

    Dr. William L. Carroll is the Julie and Edward J. Minskoff Professor of Pediatrics and associate chair for clinical and translational research in the Department of Pediatrics, and is also a professor in the Department of Pathology. Dr. Carroll treats children who have blood cancers such as leukemia and lymphoma. He also conducts research focused on discovering the molecular origins of childhood cancers, with the goal of developing improved treatment and preventive measures.

    View Full Profile